Can Co-Activation of Nrf2 and Neurotrophic Signaling Pathway Slow Alzheimer's Disease?

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2017 Jun 1

PMID 28561773

Citations 28

Authors

Kelsey E Murphy

Joshua J Park

Affiliations

Soon will be listed here.

Abstract

Alzheimer's disease (AD) is a multifaceted disease that is hard to treat by single-modal treatment. AD starts with amyloid peptides, mitochondrial dysfunction, and oxidative stress and later is accompanied with chronic endoplasmic reticulum (ER) stress and autophagy dysfunction, resulting in more complicated pathogenesis. Currently, few treatments can modify the complicated pathogenic progress of AD. Compared to the treatment with exogenous antioxidants, the activation of global antioxidant defense system via Nrf2 looks more promising in attenuating oxidative stress in AD brains. Accompanying the activation of the Nrf2-mediated antioxidant defense system that reduce the AD-causative factor, oxidative stress, it is also necessary to activate the neurotrophic signaling pathway that replaces damaged organelles and molecules with new ones. Thus, the dual actions to activate both the Nrf2 antioxidant system and neurotrophic signaling pathway are expected to provide a better strategy to modify AD pathogenesis. Here, we review the current understanding of AD pathogenesis and neuronal defense systems and discuss a possible way to co-activate the Nrf2 antioxidant system and neurotrophic signaling pathway with the hope of helping to find a better strategy to slow AD.

Citing Articles

Treadmill Exercise Training Ameliorates Apoptotic Cells and DNA Oxidation in the Cerebral Cortex of Rats Exposed to Chronic Ketamine Abuse.

Sabziparvar S, Khodaei K, Azar J Addict Biol. 2025; 30(3):e70025.

PMID: 40062767 PMC: 11892017. DOI: 10.1111/adb.70025.

Interface potential-induced natural antioxidant mimic system for the treatment of Alzheimer's disease.

Liu K, Ding Q, Cao D, Xi E, Zhao Y, Gao N Commun Chem. 2024; 7(1):206.

PMID: 39271821 PMC: 11399259. DOI: 10.1038/s42004-024-01299-9.

Trametinib activates endogenous neurogenesis and recovers neuropathology in a model of Alzheimer's disease.

Kim M, Kim M, Lee C, Lee J, Kim S, Hong S Exp Mol Med. 2023; 55(10):2177-2189.

PMID: 37779138 PMC: 10618442. DOI: 10.1038/s12276-023-01073-2.

Signaling Pathways Involved in the Neuroprotective Effect of Osthole: Evidence and Mechanisms.

Singh L, Bhatti R Mol Neurobiol. 2023; 61(2):1100-1118.

PMID: 37682453 DOI: 10.1007/s12035-023-03580-9.

Sargachromenol Isolated from Attenuates Glutamate-Induced Neuronal Cell Death and Oxidative Stress through Inhibition of MAPK/NF-κB and Activation of Nrf2/HO-1 Signaling Pathway.

Han E, Zhang C, Kim H, Kim J, Park S, Jung W Mar Drugs. 2022; 20(11).

PMID: 36421988 PMC: 9695719. DOI: 10.3390/md20110710.

References

Petersen C, Alikhani N, Behbahani H, Wiehager B, Pavlov P, Alafuzoff I . The amyloid beta-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae. Proc Natl Acad Sci U S A. 2008; 105(35):13145-50. PMC: 2527349. DOI: 10.1073/pnas.0806192105. View

Yoneda T, Imaizumi K, Oono K, Yui D, Gomi F, Katayama T . Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem. 2001; 276(17):13935-40. DOI: 10.1074/jbc.M010677200. View

Dhamoon M, Noble J, Craft S . Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology. 2009; 72(3):292-3. DOI: 10.1212/01.wnl.0000344246.91081.2c. View

Kang S, Lee J, Choi Y, Kim G, Han B . Neuroprotective effects of flavones on hydrogen peroxide-induced apoptosis in SH-SY5Y neuroblostoma cells. Bioorg Med Chem Lett. 2004; 14(9):2261-4. DOI: 10.1016/j.bmcl.2004.02.003. View

Packer L, Roy S, Sen C . Alpha-lipoic acid: a metabolic antioxidant and potential redox modulator of transcription. Adv Pharmacol. 1997; 38:79-101. DOI: 10.1016/s1054-3589(08)60980-1. View

Beck T, Lindholm D, Castren E, Wree A . Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J Cereb Blood Flow Metab. 1994; 14(4):689-92. DOI: 10.1038/jcbfm.1994.86. View

Oh K, Singh P, Lee K, Foss K, Lee S, Park M . Conformational changes in BAK, a pore-forming proapoptotic Bcl-2 family member, upon membrane insertion and direct evidence for the existence of BH3-BH3 contact interface in BAK homo-oligomers. J Biol Chem. 2010; 285(37):28924-37. PMC: 2937919. DOI: 10.1074/jbc.M110.135293. View

Leon R, Wu H, Jin Y, Wei J, Buddhala C, Prentice H . Protective function of taurine in glutamate-induced apoptosis in cultured neurons. J Neurosci Res. 2008; 87(5):1185-94. DOI: 10.1002/jnr.21926. View

Anderson A, Kendal C, Garcia-Maya M, Kenny A, Morris-Triggs S, Wu T . A peptide from the first fibronectin domain of NCAM acts as an inverse agonist and stimulates FGF receptor activation, neurite outgrowth and survival. J Neurochem. 2005; 95(2):570-83. DOI: 10.1111/j.1471-4159.2005.03417.x. View

10.

Mancuso M, Coppede F, Murri L, Siciliano G . Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality?. Antioxid Redox Signal. 2007; 9(10):1631-46. DOI: 10.1089/ars.2007.1761. View

11.

Massaad C, Washington T, Pautler R, Klann E . Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2009; 106(32):13576-81. PMC: 2726352. DOI: 10.1073/pnas.0902714106. View

12.

Hoozemans J, Veerhuis R, van Haastert E, Rozemuller J, Baas F, Eikelenboom P . The unfolded protein response is activated in Alzheimer's disease. Acta Neuropathol. 2005; 110(2):165-72. DOI: 10.1007/s00401-005-1038-0. View

13.

Hoyer S . Glucose metabolism and insulin receptor signal transduction in Alzheimer disease. Eur J Pharmacol. 2004; 490(1-3):115-25. DOI: 10.1016/j.ejphar.2004.02.049. View

14.

Butterfield D, Poon H, St Clair D, Keller J, Pierce W, Klein J . Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis. 2006; 22(2):223-32. DOI: 10.1016/j.nbd.2005.11.002. View

15.

Maines M, Trakshel G, Kutty R . Characterization of two constitutive forms of rat liver microsomal heme oxygenase. Only one molecular species of the enzyme is inducible. J Biol Chem. 1986; 261(1):411-9. View

16.

Moreira P, Cardoso S, Santos M, Oliveira C . The key role of mitochondria in Alzheimer's disease. J Alzheimers Dis. 2006; 9(2):101-10. DOI: 10.3233/jad-2006-9202. View

17.

Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm H, Born J . Intranasal insulin improves memory in humans. Psychoneuroendocrinology. 2004; 29(10):1326-34. DOI: 10.1016/j.psyneuen.2004.04.003. View

18.

Joshi G, Johnson J . The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseases. Recent Pat CNS Drug Discov. 2012; 7(3):218-29. PMC: 3625035. DOI: 10.2174/157488912803252023. View

19.

Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner B . Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 2000; 403(6765):98-103. DOI: 10.1038/47513. View

20.

Jia N, Sun Q, Su Q, Dang S, Chen G . Taurine promotes cognitive function in prenatally stressed juvenile rats via activating the Akt-CREB-PGC1α pathway. Redox Biol. 2016; 10:179-190. PMC: 5072153. DOI: 10.1016/j.redox.2016.10.004. View